Antioxidant gene therapy against neuronal cell death

Juliana Navarro-Yepes, Laura Zavala-Flores, Annadurai Anandhan, Fang Wang, Maciej Skotak, Namas Chandra, Ming Li, Aglaia Pappa, Daniel Martinez-Fong, Luz Maria Del Razo, Betzabet Quintanilla-Vega, Rodrigo Franco-Cruz

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

Oxidative stress is a common hallmark of neuronal cell death associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, as well as brain stroke/ischemia and traumatic brain injury. Increased accumulation of reactive species of both oxygen (ROS) and nitrogen (RNS) has been implicated in mitochondrial dysfunction, energy impairment, alterations in metal homeostasis and accumulation of aggregated proteins observed in neurodegenerative disorders, which lead to the activation/modulation of cell death mechanisms that include apoptotic, necrotic and autophagic pathways. Thus, the design of novel antioxidant strategies to selectively target oxidative stress and redox imbalance might represent important therapeutic approaches against neurological disorders. This work reviews the evidence demonstrating the ability of genetically encoded antioxidant systems to selectively counteract neuronal cell loss in neurodegenerative diseases and ischemic brain damage. Because gene therapy approaches to treat inherited and acquired disorders offer many unique advantages over conventional therapeutic approaches, we discussed basic research/clinical evidence and the potential of virus-mediated gene delivery techniques for antioxidant gene therapy.

Original languageEnglish (US)
Pages (from-to)206-230
Number of pages25
JournalPharmacology and Therapeutics
Volume142
Issue number2
DOIs
StatePublished - May 2014

Fingerprint

Neurodegenerative Diseases
Genetic Therapy
Cell Death
Antioxidants
Oxidative Stress
Aptitude
Nervous System Diseases
Brain Ischemia
Oxidation-Reduction
Parkinson Disease
Reactive Oxygen Species
Alzheimer Disease
Homeostasis
Nitrogen
Metals
Stroke
Viruses
Brain
Therapeutics
Research

Keywords

  • Antioxidant gene therapy
  • Brain ischemia
  • Neurodegenerative disorders
  • Oxidative stress
  • ROS
  • Virus-mediated gene delivery

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Navarro-Yepes, J., Zavala-Flores, L., Anandhan, A., Wang, F., Skotak, M., Chandra, N., ... Franco-Cruz, R. (2014). Antioxidant gene therapy against neuronal cell death. Pharmacology and Therapeutics, 142(2), 206-230. https://doi.org/10.1016/j.pharmthera.2013.12.007

Antioxidant gene therapy against neuronal cell death. / Navarro-Yepes, Juliana; Zavala-Flores, Laura; Anandhan, Annadurai; Wang, Fang; Skotak, Maciej; Chandra, Namas; Li, Ming; Pappa, Aglaia; Martinez-Fong, Daniel; Del Razo, Luz Maria; Quintanilla-Vega, Betzabet; Franco-Cruz, Rodrigo.

In: Pharmacology and Therapeutics, Vol. 142, No. 2, 05.2014, p. 206-230.

Research output: Contribution to journalReview article

Navarro-Yepes, J, Zavala-Flores, L, Anandhan, A, Wang, F, Skotak, M, Chandra, N, Li, M, Pappa, A, Martinez-Fong, D, Del Razo, LM, Quintanilla-Vega, B & Franco-Cruz, R 2014, 'Antioxidant gene therapy against neuronal cell death', Pharmacology and Therapeutics, vol. 142, no. 2, pp. 206-230. https://doi.org/10.1016/j.pharmthera.2013.12.007
Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N et al. Antioxidant gene therapy against neuronal cell death. Pharmacology and Therapeutics. 2014 May;142(2):206-230. https://doi.org/10.1016/j.pharmthera.2013.12.007
Navarro-Yepes, Juliana ; Zavala-Flores, Laura ; Anandhan, Annadurai ; Wang, Fang ; Skotak, Maciej ; Chandra, Namas ; Li, Ming ; Pappa, Aglaia ; Martinez-Fong, Daniel ; Del Razo, Luz Maria ; Quintanilla-Vega, Betzabet ; Franco-Cruz, Rodrigo. / Antioxidant gene therapy against neuronal cell death. In: Pharmacology and Therapeutics. 2014 ; Vol. 142, No. 2. pp. 206-230.
@article{38ce72b7af124b9d96a80da4f7324c66,
title = "Antioxidant gene therapy against neuronal cell death",
abstract = "Oxidative stress is a common hallmark of neuronal cell death associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, as well as brain stroke/ischemia and traumatic brain injury. Increased accumulation of reactive species of both oxygen (ROS) and nitrogen (RNS) has been implicated in mitochondrial dysfunction, energy impairment, alterations in metal homeostasis and accumulation of aggregated proteins observed in neurodegenerative disorders, which lead to the activation/modulation of cell death mechanisms that include apoptotic, necrotic and autophagic pathways. Thus, the design of novel antioxidant strategies to selectively target oxidative stress and redox imbalance might represent important therapeutic approaches against neurological disorders. This work reviews the evidence demonstrating the ability of genetically encoded antioxidant systems to selectively counteract neuronal cell loss in neurodegenerative diseases and ischemic brain damage. Because gene therapy approaches to treat inherited and acquired disorders offer many unique advantages over conventional therapeutic approaches, we discussed basic research/clinical evidence and the potential of virus-mediated gene delivery techniques for antioxidant gene therapy.",
keywords = "Antioxidant gene therapy, Brain ischemia, Neurodegenerative disorders, Oxidative stress, ROS, Virus-mediated gene delivery",
author = "Juliana Navarro-Yepes and Laura Zavala-Flores and Annadurai Anandhan and Fang Wang and Maciej Skotak and Namas Chandra and Ming Li and Aglaia Pappa and Daniel Martinez-Fong and {Del Razo}, {Luz Maria} and Betzabet Quintanilla-Vega and Rodrigo Franco-Cruz",
year = "2014",
month = "5",
doi = "10.1016/j.pharmthera.2013.12.007",
language = "English (US)",
volume = "142",
pages = "206--230",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Antioxidant gene therapy against neuronal cell death

AU - Navarro-Yepes, Juliana

AU - Zavala-Flores, Laura

AU - Anandhan, Annadurai

AU - Wang, Fang

AU - Skotak, Maciej

AU - Chandra, Namas

AU - Li, Ming

AU - Pappa, Aglaia

AU - Martinez-Fong, Daniel

AU - Del Razo, Luz Maria

AU - Quintanilla-Vega, Betzabet

AU - Franco-Cruz, Rodrigo

PY - 2014/5

Y1 - 2014/5

N2 - Oxidative stress is a common hallmark of neuronal cell death associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, as well as brain stroke/ischemia and traumatic brain injury. Increased accumulation of reactive species of both oxygen (ROS) and nitrogen (RNS) has been implicated in mitochondrial dysfunction, energy impairment, alterations in metal homeostasis and accumulation of aggregated proteins observed in neurodegenerative disorders, which lead to the activation/modulation of cell death mechanisms that include apoptotic, necrotic and autophagic pathways. Thus, the design of novel antioxidant strategies to selectively target oxidative stress and redox imbalance might represent important therapeutic approaches against neurological disorders. This work reviews the evidence demonstrating the ability of genetically encoded antioxidant systems to selectively counteract neuronal cell loss in neurodegenerative diseases and ischemic brain damage. Because gene therapy approaches to treat inherited and acquired disorders offer many unique advantages over conventional therapeutic approaches, we discussed basic research/clinical evidence and the potential of virus-mediated gene delivery techniques for antioxidant gene therapy.

AB - Oxidative stress is a common hallmark of neuronal cell death associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, as well as brain stroke/ischemia and traumatic brain injury. Increased accumulation of reactive species of both oxygen (ROS) and nitrogen (RNS) has been implicated in mitochondrial dysfunction, energy impairment, alterations in metal homeostasis and accumulation of aggregated proteins observed in neurodegenerative disorders, which lead to the activation/modulation of cell death mechanisms that include apoptotic, necrotic and autophagic pathways. Thus, the design of novel antioxidant strategies to selectively target oxidative stress and redox imbalance might represent important therapeutic approaches against neurological disorders. This work reviews the evidence demonstrating the ability of genetically encoded antioxidant systems to selectively counteract neuronal cell loss in neurodegenerative diseases and ischemic brain damage. Because gene therapy approaches to treat inherited and acquired disorders offer many unique advantages over conventional therapeutic approaches, we discussed basic research/clinical evidence and the potential of virus-mediated gene delivery techniques for antioxidant gene therapy.

KW - Antioxidant gene therapy

KW - Brain ischemia

KW - Neurodegenerative disorders

KW - Oxidative stress

KW - ROS

KW - Virus-mediated gene delivery

UR - http://www.scopus.com/inward/record.url?scp=84896399040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896399040&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2013.12.007

DO - 10.1016/j.pharmthera.2013.12.007

M3 - Review article

C2 - 24333264

AN - SCOPUS:84896399040

VL - 142

SP - 206

EP - 230

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2

ER -